Non-dietary factors associated with n-3 long-chain PUFA levels in humans - a systematic literature review
- PMID: 30688181
- PMCID: PMC6521789
- DOI: 10.1017/S0007114519000138
Non-dietary factors associated with n-3 long-chain PUFA levels in humans - a systematic literature review
Abstract
Numerous health benefits are attributed to the n-3 long-chain PUFA (n-3 LCPUFA); EPA and DHA. A systematic literature review was conducted to investigate factors, other than diet, that are associated with the n-3 LCPUFA levels. The inclusion criteria were papers written in English, carried out in adult non-pregnant humans, n-3 LCPUFA measured in blood or tissue, data from cross-sectional studies, or baseline data from intervention studies. The search revealed 5076 unique articles of which seventy were included in the qualitative synthesis. Three main groups of factors potentially associated with n-3 LCPUFA levels were identified: (1) unmodifiable factors (sex, genetics, age), (2) modifiable factors (body size, physical activity, alcohol, smoking) and (3) bioavailability factors (chemically bound form of supplements, krill oil v. fish oil, and conversion of plant-derived α-linolenic acid (ALA) to n-3 LCPUFA). Results showed that factors positively associated with n-3 LCPUFA levels were age, female sex (women younger than 50 years), wine consumption and the TAG form. Factors negatively associated with n-3 LCPUFA levels were genetics, BMI (if erythrocyte EPA and DHA levels are <5·6 %) and smoking. The evidence for girth, physical activity and krill oil v. fish oil associated with n-3 LCPUFA levels is inconclusive. There is also evidence that higher ALA consumption leads to increased levels of EPA but not DHA. In conclusion, sex, age, BMI, alcohol consumption, smoking and the form of n-3 LCPUFA are all factors that need to be taken into account in n-3 LCPUFA research.
Keywords: ALA α-linolenic acid; DPA docosapentaenoic acid; FADS fatty acid desaturase; PL phospholipids; SDA stearidonic acid; n-3 LCPUFA n-3 long-chain PUFA; Determinants; Effects; Fatty acid status; Healthy adults; Implications; Measurement; Review studies.
Figures
, Plourde et al.(
43
) NS;
, Vandal et al.(
42
) NS;
, Sfar et al. (women)(
54
);
, Sfar et al. (men)(
54
) NS;
, Fortier et al.(
40
) NS;
, Dewailly et al.(
58
);
, Dewailly et al.(
59
);
, Rees et al. g1(
41
);
, Rees et al. g2(
41
);
, Rees et al. g3(
41
);
, Rees et al. g4(
41
);
, Kuriki et al.(
46
) NS;
, Dewailly et al.(
61
);
, Babin et al.(
57
) NS.
, Kawabata et al.
(
53
) (women subjects) NS;
, Kawabata et al.
(
53
) (male subjects);
, Babin et al.
(
57
) NS;
, Walker et al.
(
39
) NS.
References
-
- Hino A, Adachi H, Toyomasu K, et al. (2004) Very long chain n-3 fatty acids intake and carotid atherosclerosis: an epidemiological study evaluated by ultrasonography. Atherosclerosis 176, 145–149. - PubMed
-
- Calder PC & Yaqoob P (2009) Omega-3 long chain polyunsaturated fatty acids and human health outcomes. Biofactors 35, 266–272. - PubMed
-
- Meyer BJ, Onyiaodike CC, Brown EA, et al. (2016) Maternal plasma DHA levels increase prior to 29 days post-LH surge in women undergoing frozen embryo transfer: a prospective, observational study of human pregnancy. J Clin Endocrinol Metab 101, 1745–1753. - PubMed
-
- Makrides M & Gibson RA (2000) Long-chain polyunsaturated fatty acid requirements during pregnancy and lactation. Am J Clin Nutr 71, 307S–311S. - PubMed
-
- GISSI Prevezione Investigators (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354, 447–455. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
